Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
NORMUNITY
Su - Non-Final Action - Mailed
Show more
Pharmaceutical preparations for treating human diseases, namely, for treating oncological, autoimmune, and immune-oncological diseases and other related diseases in the fields of oncology, autoimmune, and immune-oncology
Class 5 – Pharmaceuticals & supplements
Status timeline
- 18 Feb 2022Application filedNew Application Entered
- 30 Nov 2022Assigned to an examining attorneyAssigned To Examiner
- 28 Feb 2023Response to office action filedTeas Response To Office Action Received
- 3 Apr 2023Final refusal issuedFinal Refusal Mailed
- 5 Jun 2023Approved for publicationApproved For Pub - Principal Register
- 11 Jul 2023Published for oppositionPublished For Opposition
- 5 Sep 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 4 Mar 2024Statement-of-use extension 1 grantedSou Extension 1 Granted
- 4 Sep 2024Statement-of-use extension 2 grantedSou Extension 2 Granted
- 26 Feb 2025Statement-of-use extension 3 grantedSou Extension 3 Granted
- 4 Mar 2026Statement of use filedTeas Statement Of Use Received
- 27 Jul 2026Assigned to an examining attorneyAssigned To Examiner
- 24 Aug 2026Office action issuedNon-Final Action Written
All 52 events
| 2026-08-24 | Non-Final Action Written |
| 2026-08-24 | Non-Final Action E-Mailed |
| 2026-08-24 | Notification Of Non-Final Action E-Mailed |
| 2026-07-27 | Assigned To Examiner |
| 2026-06-12 | Case Assigned To Intent To Use Paralegal |
| 2026-06-12 | Statement Of Use Processing Complete |
| 2026-03-04 | Teas Statement Of Use Received |
| 2026-03-04 | Use Amendment Filed |
| 2025-09-15 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-08-28 | Sou Teas Extension Received |
| 2025-08-28 | Sou Extension 4 Filed |
| 2025-08-28 | Sou Extension 4 Granted |
| 2025-02-27 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-02-26 | Sou Teas Extension Received |
| 2025-02-26 | Sou Extension 3 Filed |
| 2025-02-26 | Sou Extension 3 Granted |
| 2024-10-31 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2024-10-31 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2024-10-31 | Teas Change Of Correspondence Received |
| 2024-09-04 | Sou Teas Extension Received |
| 2024-09-04 | Sou Extension 2 Filed |
| 2024-09-04 | Sou Extension 2 Granted |
| 2024-09-04 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-08-30 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2024-08-30 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2024-08-30 | Teas Change Of Correspondence Received |
| 2024-08-30 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2024-03-05 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-03-04 | Sou Teas Extension Received |
| 2024-03-04 | Sou Extension 1 Filed |
| 2024-03-04 | Sou Extension 1 Granted |
| 2023-09-05 | Noa Mailed - Sou Required From Applicant |
| 2023-07-11 | Published For Opposition |
| 2023-07-11 | Official Gazette Publication Confirmation E-Mailed |
| 2023-06-21 | Notification Of Notice Of Publication E-Mailed |
| 2023-06-05 | Examiners Amendment -Written |
| 2023-06-05 | Examiners Amendment E-Mailed |
| 2023-06-05 | Notification Of Examiners Amendment E-Mailed |
| 2023-06-05 | Examiner's Amendment Entered |
| 2023-06-05 | Approved For Pub - Principal Register |
| 2023-04-03 | Final Refusal Mailed |
| 2023-04-03 | Final Refusal E-Mailed |
| 2023-04-03 | Notification Of Final Refusal Emailed |
| 2023-02-28 | Teas Response To Office Action Received |
| 2023-02-28 | Correspondence Received In Law Office |
| 2023-02-28 | Teas/Email Correspondence Entered |
| 2022-12-08 | Priority Action Written |
| 2022-12-08 | Priority Action E-Mailed |
| 2022-12-08 | Notification Of Priority Action E-Mailed |
| 2022-11-30 | Assigned To Examiner |
| 2022-02-18 | New Application Entered |
| 2022-02-18 | New Application Office Supplied Data Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for treating human diseases, namely, for treating oncological, autoimmune, and immune-oncological diseases and other related diseases in the fields of oncology, autoimmune, and immune-oncology
First use anywhere 0 Oct 2025 · First use in commerce 0 Oct 2025
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 24 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.